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Background
In 2013, Qatar introduced a national health insurance
scheme, called “Seha.” Stage 1 of the scheme covered
women aged 12 years and older for health care and
maternity services. Stage 2 was launched in 2014, and
covered all Qatari nationals for a much broader set of
services. In the future, Stages 3 and 4 will extend cover-
age to all non-Qatari residents within the country as
well as visitors.
The National Health Insurance Company (NHIC)
manages Seha, with a Third-Party Administrator (TPA)
contracted to manage provider claims. The Supreme
Council of Health (SCH) acts as the scheme’s overall
regulator, and is responsible for activities such as speci-
fying coverage and approving pricing.
A range of steps was taken to prepare for Seha’s
launch. SCH mandated clinical coding using ICD-10-
AM, and hospitals recruited and/or trained clinical
coders to use this system. The Australian Refined Diag-
nosis Related Groups (AR-DRGs) tool was adopted, and
public sector hospitals embarked on the clinical costing
of their services.
In Stage 1, SCH decided to use a bundled payment
method for health care services. AR-DRGs were chosen
for pricing acute inpatient care, using 76 AR-DRGs rele-
vant for women and maternity services. A modification of
the Australian Tier 2 classification was adopted for specia-
list medical services, using 9 classes relevant to women’s
health. In addition, a primary health classification was
adopted based on 4 levels of complexity. Mammography
and MRI were unbundled from the specialist and primary
care service, but other imaging, laboratory, and pharmacy
services were bundled into the price. Although this
was not included in Stage 1, previous work had also
recommended the adoption of Urgency Related Groups
(URGs) classification for emergency care.
Stage 1 was implemented with a limited network
including both private and public hospitals. The launch
of Seha involved providing information to prospective
providers and conducting subsequent sessions to assist
in operationalizing the price schedule and business
rules.
Seha’s challenges for Stage 2 included: pricing a much
wider range of services than were included in Stage 1;
expanding the scheme to a wider range of providers,
including “stand alone” providers (i.e. those without the
capacity to provide ancillary services); and addressing
the limited availability of activity and cost information
from the private sector.
Materials and methods
This paper outlines the approach to pricing Stage 2,
including some of the challenges encountered, and dis-
cusses the next steps for Seha’s pricing over the next
financial year and beyond.
An initial step involved consultations with both public
and private providers. A benchmarking study of interna-
tional prices for comparable services was also underta-
ken to provide a basis for understanding the extent to
which prices and relativities aligned with other countries
both within the region and around the world.
The authors obtained available activity information
from the major government providers. AR-DRG cost
estimates were available from a previous study underta-
ken at the major government hospitals (although these
were impacted by the fact they were not based on ICD-
10-AM coded data). High-level cost estimates, which
were available for other care streams, were used towards
pricing.
Similar data from private providers were not always
available. Instead, researchers sought to use current
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price lists, aggregate costs, and summary data (where
unit record activity data were not available) from these
providers.
Results
Various payment policy options were explored and
advice developed. These included issues such as
unbundling pharmacy costs from specialist and general
practice costs and creating differential pricing for initial,
subsequent, and repeat specialist attendances. In addi-
tion, a price schedule was developed for the full range
of admitted and non-admitted services, accompanied by
a comprehensive set of business rules.
The information being gathered in Stage 2 will be
used as the basis for pricing services and fine-tuning
business rules to improve the existing methodology and
prepare for Seha’s next stage. Using the standard net-
work agreement, NHIC has gained a commitment from
all providers to report their costing data to SCH, which
will provide additional information towards pricing.
Conclusions
The design of the payment system underpinning Seha
was ambitious in beginning with a bundled model across
both inpatient and outpatient sectors. The desire for a
bundled system had to be balanced with the need to
collect information at a granular level to enable analysis
of service use and morbidity patterns, and for decision-
support in implementing the National Health Care
Strategy.
Challenges remain that will be addressed in the pri-
cing schedule’s future refinements. The first challenge is
to gain insight from claims data for use in fraud and
abuse prevention, clinical quality assessments, and cost-
efficiency evaluations.
The second is to ensure a provider structure based on a
sustainable payment model that allows providers to sus-
tain their business model, and enables payers to avoid
unsustainable cost increases over time. Qatar’s provider
structure is diverse and further costing data will generate
insights into the relationship between cost, quality, and
prices. This will enable the introduction of models that
reward providers for quality of care, while retaining the
overall philosophy of a standard price list.
The final challenge is to leverage the specific opportu-
nities provided by a new payment system to introduce
innovative models of payments and incentives — especially
with respect to bundled payments for outpatient services.
The steps taken thus far provide a beneficial starting
point for making such improvements in the future.
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